ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42576455

Integrated Molecular Docking and Dynamic Simulations Reveal Glycyrrhizic Acid Alleviates Allergic Rhinitis in Rats by Inhibiting the TLR4/NF-κB/IL-1β Pathway.

Huang J and 3 others. J Immunol Res, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Integrated Molecular Docking and Dynamic Simulations Reveal Glycyrrhizic Acid Alleviates Allergic Rhinitis in Rats by Inhibiting the TLR4/NF-κB/IL-1β Pathway. Papers, record 42576455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42576455

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrated Molecular Docking and Dynamic Simulations Reveal Glycyrrhizic Acid Alleviates Allergic Rhinitis in Rats by Inhibiting the TLR4/NF-κB/IL-1β Pathway.
PubMed
Journal
J Immunol Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang JJianquanhttps://orcid.org/0009-0007-5451-7602
2Ren XXinyuehttps://orcid.org/0000-0003-3632-7155
3Chen XXiaojinhttps://orcid.org/0009-0006-0219-9617
4Zheng XXianghttps://orcid.org/0000-0001-7675-7278

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glycyrrhizic AcidMajor topic
Toll-Like Receptor 4Major topic
Rhinitis, AllergicMajor topic
Anti-Inflammatory AgentsMajor topic
Animals
Molecular Docking Simulation
Rats
NF-kappa B
Signal Transduction
Molecular Dynamics Simulation
Disease Models, Animal
Interleukin-1beta
Ovalbumin
Male
Cytokines
Myeloid Differentiation Factor 88
Nasal Mucosa
Humans
Rats, Sprague-Dawley

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023WJC010Hangzhou Municipal Science and Technology Special Project for Supporting the Development of Biopharmaceutical and Health IndustriesPubMed
2024WJC176Hangzhou Municipal Science and Technology Special Project for Supporting the Development of Biopharmaceutical and Health IndustriesPubMed
2025HZZD19Construction Fund of Key Medical Disciplines of HangzhouPubMed
ETYY2025Y02Hangzhou Children's Hospital Institutional Research ProjectPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,938,614Quercetin improves the imbalance of Th1/Th2 cells and Treg/Th17 cells to attenuate allergic rhinitis.Autoimmunity2023https://conductscience.org/library/papers/36938614PubMed
238,388,914Three Artemisia pollens trigger the onset of allergic rhinitis via TLR4/MyD88 signaling pathway.Mol Biol Rep2024https://conductscience.org/library/papers/38388914PubMed
338,185,229Glycyrrhizic acid alleviated MI/R-induced injuries by inhibiting Hippo/YAP signaling pathways.Cell Signal2024https://conductscience.org/library/papers/38185229PubMed
430,003,405The In Vitro Impact of Glycyrrhizic Acid on CD4+ T Lymphocytes through OX40 Receptor in the Patients with Allergic Rhinitis.Inflammation2018https://conductscience.org/library/papers/30003405PubMed
539,755,645Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity.BMC Chem2025https://conductscience.org/library/papers/39755645PubMed
636,949,402Visual dynamics: a WEB application for molecular dynamics simulation using GROMACS.BMC Bioinformatics2023https://conductscience.org/library/papers/36949402PubMed
733,273,461Allergic rhinitis.Nat Rev Dis Primers2020https://conductscience.org/library/papers/33273461PubMed
830,845,812Preventive Effect of Bupleurum chinense on Nasal Inflammation via Suppressing T Helper Type 2, Eosinophil and Mast Cell Activation.Am J Chin Med2019https://conductscience.org/library/papers/30845812PubMed
934,708,566Discovery of Inhibitors for Mycobacterium Tuberculosis Peptide Deformylase Based on Virtual Screening in Silico.Mol Inform2022https://conductscience.org/library/papers/34708566PubMed
1038,176,667Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis.J Ethnopharmacol2024https://conductscience.org/library/papers/38176667PubMed

1 to 10 of 46

See all 46 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42,576,455Integrated Molecular Docking and Dynamic Simulations Reveal Glycyrrhizic Acid Alleviates Allergic Rhinitis in Rats by Inhibiting the TLR4/NF-κB/IL-1β Pathway.J Immunol Res2026https://conductscience.org/library/papers/42576455

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42576455

GET https://conductscience.org/api/papers/v1/42576455/references?page=2

API referenceFor AI assistants